Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics
Abstract
Unveiling the different biomedical functions of tumor-resident microbiota has remained challenging for the development of advanced anticancer medicines. Here we show that isolated intratumoral bacteria with its association with natural purple photosynthetic bacteria have a high innate biocompatibility and drastic immunogenic anticancer efficacies. They preferentially grow and proliferate within targeted tumor milieu, which effectively causes immune cells to infiltrate the tumor and provoke strong anticancer responses in various syngeneic mouse models including those of colorectal cancer, sarcoma, metastatic lung cancer, and extensive drug-resistant breast cancer. Furthermore, these functional bacteria-treated mice, that exhibit excellent anticancerous responses of tumors, have significantly prolonged survival rates with effective immunological memory. Notably, light-harvesting nanocomplexes of microbial consortium of intratumoral bacteria and purple photosynthetic bacteria is capable of tumor diagnosis using bio-optical-window near-infrared light, making them useful theranostic agents for highly targeted immunological elimination of the tumor and for precisely marking tumor location.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Programmable bacteria induce durable tumor regression and systemic antitumor immunity
Sreyan Chowdhury, Samuel Castro, … Tal Danino·Nature MedicinePeer-reviewed·Jul 1, 2019
- Expanding the therapeutic window of bacteria for cancer therapy
Jongwon Im, Meghna Komaranchath, … Tal Danino·bioRxiv·Oct 29, 2026
- Programming the lifestyles of engineered bacteria for cancer therapy
Shengwei Fu, Rongrong Zhang, … Fan Jin·National Science ReviewPeer-reviewed·Feb 11, 2023
- Cytosolic bacterial pathogens activate TLR pathways in tumors that synergistically enhance STING agonist cancer therapies
Meggie Danielson, Christopher J. Nicolai, … Thomas Burke·iSciencePeer-reviewed·Nov 13, 2024
- Engineering tumor-homing bacteria as membrane-anchored immune checkpoint-blockade interfaces
Zongqi Wang, Chengyuan Fang, … Jiahe Li·bioRxiv·Jun 11, 2026
- Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy
Jesse Garcia Castillo, Sebastian Fernandez, … Michel J.P. DuPage·ImmunityPeer-reviewed·Feb 20, 2024